Asset Details
Do you wish to reserve the book?
Incidence rate and risk factors of pulmonary conditions three years post COVID-19 in Bronx, New York: a retrospective cohort study
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Incidence rate and risk factors of pulmonary conditions three years post COVID-19 in Bronx, New York: a retrospective cohort study
Do you wish to request the book?
Incidence rate and risk factors of pulmonary conditions three years post COVID-19 in Bronx, New York: a retrospective cohort study
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Incidence rate and risk factors of pulmonary conditions three years post COVID-19 in Bronx, New York: a retrospective cohort study
2025
Overview
This retrospective cohort study used propensity-matched cohorts with a 3-year follow-up (March 2020–July 2023) to determine incidence rates, relative risks, and risk factors for incident pulmonary conditions after COVID-19 exposure. Data were drawn from a multi-center health system in New York City. Participants had at least 30 days of follow-up and included patients with or without COVID-19 confirmed by PCR, diagnosed with lower respiratory tract infection (LRTI), or without COVID-19/LRTI testing. COVID-19 status was defined by positive PCR, LRTI requiring hospitalization, or neither. The final cohort (
n
= 69,632) comprised 1:1 propensity-matched comparisons based on age, sex, race/ethnicity, obesity, type II diabetes, hypertension, and smoking, stratified by hospitalization. Primary outcomes were incidence rates, hazard ratios (HRs), and incidence rate ratios (IRRs) for new-onset pulmonary conditions. The study included 34,816 matched COVID-19 survivors and 34,816 non-COVID survivors. Non-hospitalized COVID-19 patients had a threefold higher risk of incident pulmonary conditions compared to non-COVID controls (aHR = 3.36, 95% CI: 3.02–3.73). Hospitalized COVID-19 patients showed similar risk to hospitalized LRTI controls (aHR = 1.24, 95% CI: 0.84–1.84). Multiple sensitivity analyses were conducted. COVID-19 increases pulmonary risk in non-hospitalized patients but not in hospitalized cohorts compared with LRTI. These findings underscore the need for monitoring and intervention in at-risk individuals.
Publisher
Nature Publishing Group UK,Nature Publishing Group,Nature Portfolio
Subject
/ Adult
/ Aged
/ Asthma
/ Chronic obstructive pulmonary disease
/ COVID-19
/ Einstein, Albert (1879-1955)
/ Female
/ Hospitalization - statistics & numerical data
/ Humanities and Social Sciences
/ Humans
/ Lung Diseases - epidemiology
/ Male
/ New York City - epidemiology
/ Obesity
/ Patients
/ SARS-CoV-2 - isolation & purification
/ Science
